Association of polymorphisms in the interleukin 6 receptor complex with obesity and hyperandrogenism

Obesity Research

Volumn 11, Issue 8, 2003, Pages 987-996

  Escobar Morreale, Héctor F ^a   Calvo, Rosa M ^a   Villuendas, Gemma ^a   Sancho, José ^a   San Millán, José L ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Gp130; Il6r ; Insulin resistance; Metabolic syndrome; Polycystic ovary syndrome

Indexed keywords

EID: 1442321080     PISSN: 10717323     EISSN: None     Source Type: Journal    
DOI: 10.1038/oby.2003.136     Document Type: Article

References (35)

1. Carmina E, Lobo RA. Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women. J Clin Endocrinol Metab. 1999;84:1897-9.
2. Asunción M, Calvo RM, San Millán JL, Sancho J, Avila S, Escobar-Morreale HF. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab. 2000;85:2434-8.
3. Legro RS, Driscoll D, Strauss JF III, Fox J, Dunaif A. Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proc Natl Acad Sci USA. 1998;95:14956-60.
4. Fernandez-Real JM, Ricart W. Insulin resistance and inflammation in an evolutionary perspective: the contribution of cytokine genotype/phenotype to thriftiness. Diabetologia. 1999;42:1367-74.
5. Witchel SF, Lee PA, Suda-Hartman M, Trucco M, Hoffman EP. Evidence for a heterozygote advantage in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab. 1997;82:2097-101.
6. Stearns SC, Ackermann M, Doebeli M, Kaiser M. Experimental evolution of aging, growth, and reproduction in fruitflies. Proc Natl Acad Sci USA. 2000;97:3309-13.
7. Parsons P. Success in mating: a coordinated approach to fitness through genotypes incorporating genes for stress resistance and heterozygous advantage under stress. Behav Genet. 1997;27:75-81.
8. Kelly CCJ, Lyall H, Petrie JR, Gould GW, Connell JMC, Sattar N. Low grade chronic inflammation in women with polycystic ovarian syndrome. J Clin Endocrinol Metab. 2001;86:2453-5.
9. Escobar-Morreale HF, Calvo RM, Sancho J, San Millán JL. TNF-α and hyperandrogenism: a clinical, biochemical and molecular genetic study. J Clin Endocrinol Metab. 2001;86:3761-7.
10. Peral B, San Millan JL, Castello R, Moghetti P, Escobar-Morreale HF. The methionine 196 arginine polymorphism in exon 6 of the TNF receptor 2 gene (TNFRSF1B) is associated with the polycystic ovary syndrome and hyperandrogenism. J Clin Endocrinol Metab. 2002;87:3977-83.
11. Villuendas G, San Millan JL, Sancho J, Escobar-Morreale HF. The -597 G → A and -174 G → C polymorphisms in the promoter of the interleukin 6 gene (IL6) are associated with hyperandrogenism. J Clin Endocrinol Metab. 2002;87:1134-41.
12. Gambineri A, Pelusi C, Vicennati V, Pagotto U, Pasquali R. Obesity and the polycystic ovary syndrome. Int J Obes Relat Metab Disord. 2002;26:883-96.
13. Moller DE. Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes. Trends Endocrinol Metab. 2000;11:212-7.
14. Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis. 2000;148:209-14.
15. Fried SK, Bunkin DA, Greenberg AS. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab. 1998;83:847-50.
16. Bastard JP, Jardel C, Bruckert E, et al. Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab. 2000;85:3338-42.
17. Haan C, Heinrich PC, Behrmann I. Structural requirements of the interleukin-6 signal transducer gp130 for its interaction with Janus kinase 1: the receptor is crucial for kinase activation. Biochem J. 2002;361:105-11.
18. Azziz R, Dewailly D, Owerbach D. Nonclassic adrenal hyperplasia: current concepts. J Clin Endocrinol Metab. 1994;78:810-5.
19. Zawadzki JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: Towards a rational approach. In: Dunaif A, Givens JR, Haseltine FP, Merriam GR, eds. Polycystic Ovary Syndrome. Current Issues in Endocrinology and Metabolism. Boston, MA: Blackwell Scientific Publications; 1992, pp. 377-84.
20. Escobar-Morreale HF, Peral B, Villuendas G, Calvo RM, Sancho J, San Millan JL. Common single nucleotide polymorphisms in intron 3 of the calpain-10 gene influence hirsutism. Fertil Steril. 2002;77:581-7.
21. San Millan JL, Sancho J, Calvo RM, Escobar-Morreale HF. Role of the pentanucleotide (tttta)n polymorphism in the promoter of the CYP11a gene in the pathogenesis of hirsutism. Fertil Steril. 2001;75:797-802.
22. Escobar-Morreale HF, Serrano-Gotarredona J, Varela C, García-Robles R, Sancho JM. Circulating leptin concentrations in women with hirsutism. Fertil Steril. 1997;68:898-906.
23. Escobar-Morreale HF, Avila S, Sancho J. Serum prostate-specific antigen concentrations are not useful for monitoring the treatment of hirsutism with oral contraceptive pills. J Clin Endocrinol Metab. 2000;85:2488-92.
24. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab. 1999;84:3666-72.
25. Bastard JP, Grimaldi A, Jardel C, Porquet D, Bruckert E, Hainque B. A simple index of insulin resistance. Diabetes Metab. 1997;23:87-8.
26. Tsukamoto K, Ohta N, Shirai Y, Emi M. A highly polymorphic CA repeat marker at the human interleukin 6 receptor (IL6R) locus. J Hum Genet. 1998;43:289-90.
27. Rodriguez C, Grosgeorge J, Nguyen VC, Gaudray P, Theillet C. Human gp130 transducer chain gene (IL6ST) is localized to chromosome band 5q11 and possesses a pseudogene on chromosome band 17p11. Cytogenet Cell Genet. 1995;70:64-7.
28. Rodriguez C, Theillet C, Portier M, Bataille R, Klein B. Molecular analysis of the IL-6 receptor in human multiple myeloma, an IL-6-related disease. FEBS Lett. 1994;341:156-61.
29. Norusis MJ. SPSS Regression Models, 10th ed. Chicago, IL: SPSS Inc.; 2000.
30. Legro RS, Spielman R, Urbanek M, Driscoll D, Strauss JF III, Dunaif A. Phenotype and genotype in polycystic ovary syndrome. Recent Prog Horm Res. 1998;53:217-56.
31. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev. 1997;18:774-800.
32. Legro RS, Bentley-Lewis R, Driscoll D, Wang SC, Dunaif A. Insulin resistance in the sisters of women with polycystic ovary syndrome: association with hyperandrogenemia rather than menstrual irregularity. J Clin Endocrinol Metab. 2002;87:2128-33.
33. Papanicolaou DA, Vgontzas AN. Interleukin-6: the endocrine cytokine. J Clin Endocrinol Metab. 2000;85:1331-3.
34. Mohamed-Ali V, Goodrick S, Rawesh A, et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab. 1997;82:4196-200.
35. Bastard JP, Maachi M, Tran Van Nhieu J, et al. Adipose tissue IL-6 content correlated with resistance to insulin activation of glucose uptake both in vivo and in vitro. J Clin Endocrinol Metab. 2002;87:2084-9.